ShumeiMengMDPhD

Division Chief of Endocrinology, Baylor University Medical Center, Dallas

Dr. Meng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3500 Gaston Ave
Truett Suite 248A
Dallas, TX 75246
Phone+1 214-820-6232

Fax+1 214-820-6385

My mission is to build an inpatient endocrine service that will provide excellent care to treat general endocrine diseases including diabetes, thyroid diseases, metabolic bone disease, and other rare endocrine conditions such as islet transplant and endocrine diseases in transplant patients. In addition, I would like to devote to medical education and commit to clinical research.

Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2013
University of Mississippi Medical CenterResidency, Internal Medicine, 2007 - 2010

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

44 citations
Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients.
Priyamvada Singh, Todd E. Pesavento, Kenneth Washburn, Debbie Walsh, Shumei Meng
Diabetes, Obesity & Metabolism. 2019-04-01
18 citations
Potential Biomarker of Metformin Action
Ling He, Shumei Meng, Emily L. Germain-Lee, Sally Radovick, Fredric E. Wondisford
The Journal of Endocrinology. 2014-06-01
70 citations
Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.
Mayumi Endo, Fadi Nabhan, Kyle Porter, Katie Roll, Lawrence A. Shirley
Thyroid. 2019-08-19

Lectures

Guided Posters: Diabetes and Glucose Metabolism
ENDO 2019 - New Orleans, LA - 3/24/2019

Type 1 Diabetes: The Benefits and Limitations of a Pancreas TransplantNovember 15th, 2022